Crescent Biopharma, Inc.CBIONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.0%
5Y CAGR+8.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+10.0%/yr
vs +13.7%/yr prior
5Y CAGR
+8.7%/yr
Consistent
Acceleration
-3.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $25.39M | +101.1% |
| 2024 | $12.63M | -34.3% |
| 2023 | $19.21M | +0.7% |
| 2022 | $19.09M | +11.5% |
| 2021 | $17.12M | +2.2% |
| 2020 | $16.74M | +16.6% |
| 2019 | $14.36M | +25.8% |
| 2018 | $11.41M | +16.1% |
| 2017 | $9.83M | +13.7% |
| 2016 | $8.65M | - |